XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 1.4500
- -0.0100-0.68%
Close Feb 14 16:00 ET
- 1.3614
- -0.0886-6.11%
Post 19:50 ET
1.84MMarket Cap-0.10P/E (TTM)
1.5380High1.4400Low170.21KVolume1.4800Open1.4600Pre Close251.05KTurnover18.73%Turnover RatioLossP/E (Static)1.27MShares9.250052wk High0.10P/B1.32MFloat Cap1.320052wk Low--Dividend TTM908.92KShs Float170.0000Historical High--Div YieldTTM6.71%Amplitude1.3200Historical Low1.4740Avg Price1Lot Size
Pasithea Therapeutics News
SCHEDULE 13G/A: Others
8-K: Current report
424B5: Prospectus
SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
10-Q: Q3 2024 Earnings Report
EFFECT: Others
424B3: Prospectus
UPLOAD: Others
CORRESP: CORRESP
S-3: Registration statement for specified transactions by certain issuers
8-K: Current report
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director Novak Alfred J
ARS: Annual Report to Security Holders
DEF 14A: Definitive information statements
8-K: Current report
10-Q: Q1 2024 Earnings Report
Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Marques Tiago
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!